Access links:
CONTENT
Destacados
Viral Entry and Pathogenesis
Publications
-
Beta5 integrin is the major contributor to the alphav integrin-mediated blockade of HIV-1...
Journal of Immunology 186:464-470.
-
Diarylpyrimidine-Dihydrobenzyloxopyrimidine Hybrids: New, Wide-Spectrum Anti-HIV-1
Journal of Medicinal Chemistry
-
ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block the fusion-active gp41...
Antimicrobial Agents Chemotherapy 54:4487-4492
-
Endocytosis of HIV
Trends in Microbiology 18:543-551.
Seminars and Congresses
2nd Antivirals Congress: From Bench to Bedside
11.11.1211-13 November 2012 | Cambridge, MA, USA The key objectives of this congress are: To provide a state-of-the-art report for scientists,...
- 09.07.12 - 12.07.12
I Congrés Internacional de Biologia de Catalunya: Global Questions on Advanced Biology
The Organising Committee of the Global Questions in Advanced Biology Conference is pleased to invite you...
More information - 21.05.12 - 21.05.12
Seminar on HIV: Treatment, prevention and eradication
The Fundación Valenciana de Estudios Avanzados organises a seminar on the treatment, the prevention and the eradication of the...
More information
Projects
In vitro evaluation of the effect of inhibitors of HIV-1 entry on mobilization to lymphoid tissue and HIV-envelope...
Financing entity: Pfizer
Participant entities: Fundació IrsiCaixa
